John discusses the complexities of health policy, emphasizing the need for a rational approach to pharmaceutical pricing. He highlights the importance of balancing financial interests with patient access while preparing for future political opportunities. By taking a long-term view, he aims to develop solutions that could be enacted when the political climate shifts.
